Crossmark

Rolipram and pentoxifylline combination ameliorates experimental diabetic neuropathy through inhibition of oxidative stress and inflammatory pathways in the dorsal root ganglion neurons

Crossref DOI link: https://doi.org/10.1007/s11011-022-01060-y

Published Online: 2022-08-04

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dastgheib, Mona

Shetab-Boushehri, Seyed Vahid

Baeeri, Maryam

Gholami, Mahdi

Karimi, Mohammad Yahya

Hosseini, Asieh http://orcid.org/0000-0003-2712-2799
License Information

Text and Data Mining valid from 2022-08-04

Version of Record valid from 2022-08-04
More Information

Article History

Received: 4 January 2022

Accepted: 30 July 2022

First Online: 4 August 2022

Change Date: 11 October 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s11011-023-01305-4

Declarations

:

: The authors declare no conflict of interest.

Updates are available Correction dated 2023-10-11

Click to view Correction: https://doi.org/10.1007/s11011-023-01305-4